Clinical Picture and Outcome of Transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 12, 2002, Pages 1257-1261

  Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Familial amyloid polyneuropathy

Indexed keywords

AMINO ACID; AMYLOID; LIVER PROTEIN; PREALBUMIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; CLINICAL FEATURE; ENDEMIC DISEASE; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; GENETIC DISORDER; HUMAN; JAPAN; LIVER TRANSPLANTATION; OUTCOMES RESEARCH; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REVIEW;

AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; HUMANS; JAPAN; LIVER; LIVER TRANSPLANTATION; MALE; MUTATION; PREALBUMIN; TREATMENT OUTCOME;

EID: 0036915722     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.217     Document Type: Review

References (27)

1. Ikeda S, Hanyu N, Hongo M, Yoshioka J, Oguchi H, Yanagisawa N, et al. Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain 1987; 110:315-37.
2. Connor LH, Richardson AM, Theberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000; 7:54-69.
3. Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y-F, et al. Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid 1999; 6:282-8.
4. Araki S, Mawatari S, Ohta M, Nkajima A, Kuroiwa Y. Polyneuritic amyloidosis in a Japanese family. Arch Neurol 1968; 18:593-602.
5. Kito S, Itoga E, Kamiya K, Kishida T, Yamamura Y. Studies on familial amyloid polyneuropathy in Ogawa village, Japan. Eur Neurol 1980; 19:141-51.
6. Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999; 122:1951-62.
7. Ueno S, Fujimura H, Yorifuji S, Nakamura Y, Takahashi M, Tarui S, Yanagihara T. Familial amyloid polyneuropathy with the transthyretin Cys 114 gene in a Japanese kindred. Brain 1992; 115:1275-89.
8. Olofsson BO, Andersson R, Furberg B. Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Scand 1980; 208:77-80.
9. Takahashi K, Sakashita N, Ando Y, Suga M, Ando M. Late onset type I familial amyloidotic polyneuropathy: presentation of three autopsy cases in comparison with 19 autopsy cases of the ordinary type. Pathol Int 1997; 47:353-9.
10. Nakamura Y, Yutani C, Nakazato M, Date Y, Baba T, Goto Y. A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells. Pathol Int 1999; 49:898-902.
11. Yoshinaga T, Nakazato M, Ikeda S, Ohnishi A. Homozygosity for the transthyretin-Met30 gene in three Japanese siblings with type I familial amyloidotic polyneuropathy. Neurology 1992; 42:2045-7.
12. Ikeda S, Nakano T, Yanagisawa N, Nakazato M, Tsukagoshi H. Asymptomatic homozygous gene carrier in a family with type I familial amyloid polyneuropathy. Eur Neurol 1992; 32:308-13.
13. Mochizuki H, Kamakura K, Masaki T, Hirata A, Tokuda T, Yazaki M, et al. Nodular cutaneous amyloidosis and carpal tunnel syndrome due to the amyloidogenic transthyretin His 114 variant. Amyloid 2001; 8:105- 10.
14. Ushiyama M, Ikeda S, Yanagisawa N. Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy. Acta Neuropathol 1991; 81:524-8.
15. Hongo M, Ikeda S. Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy. Circulation 1986; 73:249-56.
16. Hongo M, Hirayama J, Fujii T, Yamada H, Okubo S, Kusama S, Ikeda S. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy. Am Heart J 1987; 113: 654-62.
17. Yazaki M, Takei Y, Katoh M, Ikeda S. Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala. Amyloid 2000; 7:270-7.
18. Benson MD, Wallace MR, Tejada E, Baumann H, Page B. Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy, Appalachian amyloid. Arthritis Rheum 1987; 30:195-300.
19. Kotani N, Hattori T, Tamagata S, Tokuda T, Shirasawa A, Yamaguchi S, et al. Tranthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy. Amyloid 2002; 9:31-4.
20. Soprano DR, Herbert J, Soprano KJ, Schon EA, Goodman DS. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem 1985; 260:11793-8.
21. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, etal. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991; 40:242-6.
22. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341:1113-6.
23. Ikeda S, Takei Y, Yanagisawa N, Matsunami H, Hashikura Y, Ikegami T, et al. Partial liver transplantation from living donors in familial amyloid polyneuropathy. Amyloid 1997; 4:18-23.
24. Takei Y, Ikeda S, Hashikura Y, Ikegami T, Kawasaki S. Partial-liver transplantation to treat familial amyloid polyneuropathy: follow-up of 11 patients. Ann Intern Med 1999; 131:592-5.
25. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloidotic polyneuropathy after liver transplantation. Neurology 1996; 47:944-51.
26. Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PMP, Feray C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000; 123:1495-504.
27. Jonsen E, Suhr OB, Tashima K, Athlin E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid 2001; 8:51-7.